Clinical Trial Update: Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating enzalutamide plus dutasteride or finasteride as first-line treatment for men aged 65 and older with prostate cancer has completed, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• Enzalutamide (enzalutamide)
• FINASTERIDE (FINASTERIDE)

Snippet

Sponsor: University of Rochester | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-11-13